Empress Therapeutics
Cambridge
About Empress Therapeutics
Empress Therapeutics is a biotechnology business in its early stages focused on drug development and new molecular insights into health and illness. The company's proprietary bio platform uses evolution, human molecular and genetic data, and artificial intelligence to identify advanced starting points in endogenous drug-like molecules, allowing clinicians to treat a wide range of serious unmet medical needs with small-molecule drug candidates.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $50.0M
- Last round: Series Unknown (Jun 2023)
- Website: empresstx.com
Industries & Categories
Artificial Intelligence (AI), Biotechnology, Medical, Product Research
Social Profiles
Canonical: https://fsome.com/organization/empress-therapeutics-51474 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.